PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1005255

[New polymers for transfusiology].

I N Ermolenko·E D Buglov·S I Dovgalev·I P Liubliner
View original source ↗Export metadata ↓

Abstract

The Institute of General and Inorganic Chemistry of the BSSR Academy of Sciences and the Byelorussian Research Institute of Blood Transfusion have developed and used in hospital practice a fundamentally new method of blood stabilization which does not require addition of alliens. Some part of calcium from blood plasma is extracted by filtrating the blood through layers of specially developed highly effective and biologically compatible fibrous sorbents of derivatives of cellulose (natural highpolymer). The blood may the used in all cases of homotransfusion and most expediently in extremely complicated cases, when direct blood transfusions are difficult. Stabilized blood may also be effectively used when large-quantity or exchange blood transfusions have to be quickly performed, to resuscitate patients from clinical death, to stop haemorrhage caused by disturbances in blood coagulation, to treat anaemia of different etiology, including radiation illness, and in case of sensitiveness to citrate solutions (serious affections of kidneys, liver and heart).

Explore related subjects

Blood TransfusionCalciumExchange Transfusion, Whole BloodFiltrationPolymersEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

I N Ermolenko, E D Buglov, S I Dovgalev, I P Liubliner. 1976. [New polymers for transfusiology].. https://pubmed.ncbi.nlm.nih.gov/1005255/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

The role of vertical transmission and health care-related factors in HIV infection of children: a community study in rural Uganda.

OBJECTIVES: To determine the probable route of transmission of HIV to children aged 12 years or younger in a rural area of Uganda from 1999 through 2000 and to examine associations between HIV infection and health care-related variables. METHODS: The HIV infections status for 6991 children was determined from 1 round of an ongoing population surveillance system, and the reported numbers of injections in the past year and blood transfusions were determined for 5922 of these children based on a medical questionnaire. Data from the surveillance system and from an additional survey were used to assess the potential for vertical infection from a mother to her child. RESULTS: The HIV prevalence among children was 0.4%. Of 23 definite and 4 probable cases of HIV infection in children, vertical transmission was not possible for 1 case, not likely for another case, and possibly not vertical for another case. The population-attributable fraction for vertical transmission was between 90% and 94%. Large numbers of injections in the past year and ever having a blood transfusion were only associated with HIV infection in children exposed to vertical transmission. CONCLUSIONS: Up to 10% of HIV infections in children in the study area were not attributable to vertical transmission, and thus were possibly attributable to iatrogenic transmission. Associations seen between health care-related variables and HIV were likely to be attributable to treatment for AIDS-related illness in children infected vertically.

Blood Transfusion↗
PubMed2007

Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.

This paper describes the trends in haematopoietic stem cell transplantation (HSCT) activity for children in Europe over the last three decades. We analysed 31,713 consecutive paediatric HSCTs reported by the European Group for Blood and Marrow Transplantation (EBMT) centres between 1970 and 2002. Data were taken from the EBMT registry and were compared according to period and centre category (paediatric or combined). Since 1996, there has been a significant increase in the number of HSCTs performed exclusively by paediatric centres, as well as in the number of alternative donor HSCTs, and in the use of peripheral blood stem cells (P<0.0001). The number of allogeneic HSCTs (allo-HSCTs) for acute lymphoblastic leukaemia, acute myeloblastic leukaemia and chronic myeloid leukaemia remained stable, whereas it increased for myelodysplastic syndromes and lymphomas, and decreased significantly for non-malignant diseases (P<0.0001). Multivariate analysis showed that younger age, human leukocyte antigen genoidentical donors, HSCT performed after 1996 and transplant centres performing more than 10 allo-HSCT/year were all associated with decreased transplant-related mortality (TRM) (P<0.0001). The number of autologus HSCTs (auto-HSCTs) for acute leukaemia decreased significantly, whereas it increased for solid tumours (P<0.0001). Multivariate analysis showed that both auto-HSCT performed before 1996 and paediatric solid tumours (P<0.0001) had higher TRM. Indications for paediatric HSCT have changed considerably during the last seven years. These changes provide tools for decision making in health-care planning and counselling.

Blood Transfusion↗